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Abstract
Background: Obesity causes insulin resistance in target tissues - skeletal muscle, adipose tissue, liver and the brain.
Insulin resistance predisposes to type-2 diabetes (T2D) and cardiovascular disease (CVD). Adipose tissue
inflammation is an essential characteristic of obesity and insulin resistance. Neuronatin (Nnat) expression has been
found to be altered in a number of conditions related to inflammatory or metabolic disturbance, but its
physiological roles and regulatory mechanisms in adipose tissue, brain, pancreatic islets and other tissues are not
understood.
Results: We identified transcription factor binding sites (TFBS) conserved in the Nnat promoter, and transcription
factors (TF) abundantly expressed in adipose tissue. These include transcription factors concerned with the control
of: adipogenesis (Pparg, Klf15, Irf1, Creb1, Egr2, Gata3); lipogenesis (Mlxipl, Srebp1c); inflammation (Jun, Stat3); insulin
signalling and diabetes susceptibility (Foxo1, Tcf7l2). We also identified NeuroD1 the only documented TF that
controls Nnat expression. We identified KEGG pathways significantly associated with Nnat expression, including
positive correlations with inflammation and negative correlations with metabolic pathways (most prominently
oxidative phosphorylation, glycolysis and gluconeogenesis, pyruvate metabolism) and protein turnover. 27 genes,
including; Gstt1 and Sod3, concerned with oxidative stress; Sncg and Cxcl9 concerned with inflammation; Ebf1,
Lgals12 and Fzd4 involved in adipogenesis; whose expression co-varies with Nnat were identified, and conserved
transcription factor binding sites identified on their promoters. Functional networks relating to each of these genes
were identified.
Conclusions: Our analysis shows that Nnat is an acute diet-responsive gene in white adipose tissue and
hypothalamus; it may play an important role in metabolism, adipogenesis, and resolution of oxidative stress and
inflammation in response to dietary excess.
Background
The WHO estimates there will be 2.3 billion overweight
or obese adults world-wide by 2015; including 60% of
adults and alarmingly 25% of children in developing
countries http://www.who.int. This overweight and
obesity epidemic is predicted to affect half the global
population by 2025[1,2], largely because of increased
urbanization, adaptation of the western diet, and seden-
tary lifestyle, particularly in China and India.
A serious and nearly ubiquitous complication of
obesity is defective insulin signalling in target tissues -
skeletal muscle, liver, adipose tissue and brain. Insulin
resistance unites obesity with a major disease cluster -
diabetes, fatty liver and heart disease - through compen-
satory hyperinsulinaemia leading to pancreatic b-cell
failure, and complicating dyslipidaemia and hyperten-
sion, major risk factors for CVD. T2D affects 150 mil-
lion people world-wide, and is estimated to double by
2025[1,2]. CVD is predicted to be the leading cause of
death globally by 2020[3,4]. Dementia and cancer are
also more common in the obese [4,5]. Therefore, under-
standing the mechanisms underlying obesity and insulin
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and more effective treatments grows.
Insulin resistance in obesity is causally associated with
macrophage influx and low-grade, metabolic inflamma-
tion in adipose tissue. Macrophage-driven chronic
inflammation in adipose tissue from the obese is consid-
ered to be triggered by endoplasmic reticulum (ER) and
oxidative stress, together with hypoxia consequent on
adiposity expansion and inadequate blood supply. Cellu-
lar stress leads to activation of stress kinesis and inflam-
matory effectors such as Jnk and Nfkb, with systemic
release of cytokine and fatty acid mediators, which inhi-
bit insulin signalling in target tissues[1-7].
While appetite, energy expenditure and metabolism
are all critically regulated by hypothalamic brain circuits,
white adipose tissue (WAT) is the major storage site for
fat in the form of triglycerides, and therefore forms a
repository balancing energy intake and expenditure. The
overall adipose tissue burden of an individual is a com-
bination of adiposity number (i.e. adipogenesis) and
lipid load per cell (i.e. lipogenesis), and both processes
may contribute to the adipose tissue mass in obesity.
Nnat is a paternally expressed imprinted gene first
discovered in the developing brain and it is implicated
in antenatal brain development and foetal growth[6-9].
In adult rodents and humans Nnat is highly expressed
in neurons in many brain regions, including hypothala-
mic nuclei concerned with appetite regulation, and is
concerned in nutrient sensing, and responds to feeding/
fasting and leptin[10,11]. Nnat is also highly expressed
in adult white adipose tissue and aortic endothelial cells,
where expression is increased in obese and diabetic
rodents[12,13]. Nnat is moreover expressed in pancrea-
tic b-cell lines, where expression is glucose-dependent,
and reduced in diabetic rodents[14-16]. By contrast
Nnat expression in WAT is substantially reduced in
lipodystrophic, in lean S6kko mice and in mice fed con-
jugated linoleic acid, which induces weight loss[16-18].
Recently a consistent association between single nucleo-
tide polymorphisms in the human Nnat gene and severe
obesity in both children and adults has been demon-
strated[10]. This observation suggests that altered Nnat
function in adipose tissue or the hypothalamic regions
regulating energy homeostasis may be involved in the
pathogenesis of human obesity.
Nnat has three exons, and resides within a large
intron of Blcap[7,8], tissue specific enhancers lie well
upstream of the CpG-rich Nnat promoter. Knowledge
about the upstream regulation of Nnat is confined to
the b-cell and control by NeuroD1, a transcription factor
important for neuronal and endocrine cell differentia-
tion and survival[14].
Knowledge concerning downstream effecter mechan-
isms through which Nnat operates, and its physiological
functions are limited. Nnat is an amphipathic proteoli-
pid. It has two isoforms, a of 81 and b of 54 amino
acids, generated by alternative splicing of the middle
exon, encoding a membrane-binding domain[13-15,19].
Both isoforms reside in the endoplasmic ER membranes,
the b-isoform is implicated in ER stress and b-cell apop-
tosis[15], it is considered to regulate ER calcium ATPase
through homology to other proteolipid. Nnat expression
in vitro is associated with calcium-induced 3T3-L1 cell
adipogenesis; glucose-stimulated, calcium-induced, insu-
lin secretion from b-cells; activation of Pi3k, Erk, mTor
and calcium signalling in medulloblastoma; Nfkb-regu-
lated inflammation in aortic endothelial cells and pro-
tection against mitochondrial toxins and ionophores in
PC12 cells and resolution of injury after ischemic/reper-
fusion of the kidney [12-14,19,20].
The physiological roles of Nnat in the brain, pancreas,
adipose and other tissues are not understood. Through
genome-wide gene expression analysis we sought to
improve our understanding of the mechanisms of Nnat
regulation and its biological functions. First we carried
out an integrated bioinformatics analysis of the con-
served Nnat promoter in seven species and derived a
candidate list of potential Nnat transcription factors.
Then we interrogated multi-tissue gene expression data
to look for primary evidence on the applicability of
potential Nnat transcriptional regulators. We then used
Gene Set Enrichment Analysis[21] to understand which
biological functions are most highly correlated with
Nnat expression. Finally, we generated a mouse protein-
protein interaction network in adipose tissue to probe
the biological relationships among genes forming a
co-expression network with Nnat.
Methods
Microarray datasets and meta-analysis
In this study, we used four different microarray gene
expression datasets from WAT of C57BL/6J mice, as
described below, to complete a meta-analysis. The first
dataset designated BAIR was obtained as part of the
Biological Atlas of Insulin Resistance (BAIR, http://
www.bair.org.uk) project, a multi-lab collaborative effort
to define gene expression changes involved in insulin
signalling and resistance. Male mice were weaned at 3
weeks of age and fed a control chow diet containing 5%
w/w fat, 19% protein and 3.5% fibre (S&K Universal Ltd,
H u l l ,U K ) .A t5w e e k so fa g e ,ag r o u po fm i c ew a s
transferred to 40% w/w high-fat diet, of which saturated
fat is 40%, containing 32% pig fat, 8% casein fat, 19%
protein, 21% glucose (Special Diet Services, Witham,
UK) ad libitum, whereas the control group remained on
chow. Mice fat-fed for 2 days, 8 days, 3 weeks and 15
weeks, and with age-matched controls, were killed and
epididymal WAT was obtained for microarray gene
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4302 microarray. From these four time points a total of
40 Affymetrix gene expression raw CEL files were pro-
duced and RMA normalized by using the Affy package
http://www.bioconductor.org; present/absent call infor-
mation was also calculated based on Affymetrix MAS5
algorithm. This dataset has been deposited in EBI
ArrayExpress Database with accession number E-BAIR-12
http://www.ebi.ac.uk/microarray-as/ae/.
The second dataset was obtained from the Gene
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.
gov/geo/, accession ID: GSE4671), which contains 28
Affymetrix mouse genome 4302 chips. Nine-week old
male mice in this experiment were fed with either a
control chow diet or a chow diet that also contained
0.5% conjugated linoleic acid (CLA). At each of seven
time points (day 1, 2, 3, 4, 7, 10, 17), retroperitoneal
WAT was obtained from two control mice and two test
mice. Microarray data were processed using GCRMA
algorithm.
The third dataset was also acquired from GEO with
accession number GSE8831, in which 20 female and 15
male C57BL/6J mice, fed by ad libitum,v a r i e di nb o d y
weight and insulin sensitivity were studied. Fasting
blood glucose and serum insulin concentrations were
measured 2-4 days prior to collection of adipose tissue.
RNA from perigonadal adipose tissue was extracted and
processed for analysis on Affymetrix Mu74Av2 microar-
rays. RMA normalization was applied to the 35 raw CEL
files, and MAS5 present/absent call information was
calculated as well.
The fourth dataset consisted of 13 Affymetrix
MG-U74av2 chips for epididymal WAT extracted from
six-week old C57BL/6J male mice from the Diabetes
Genome Anatomy Project DGAP http://www.diabetes-
genome.org. There were four high-fat feeding mice
(derives 55% calories from fat, 21% calories from pro-
tein, 24% calories from carbohydrates), nine low-fat
feeding control mice (derives 14% calories from fat, 25%
calories from protein and 61% calories from carbohy-
drates). Gene expression data was RMA normalized with
present/absent call information.
In order to identify the gene co-vary with Nnat in
WAT, we calculated Pearson correlation coefficients
between the expression of Nnat and all other genes in
each of the above four datasets separately, and chose
genes showing the highest correlation with Nnat expres-
sion. Subsequently, rather than merely combining the
p-values of the Pearson correlation coefficients, we used
weighted unbiased Pearson statistical values, i.e. we nor-
malized the statistical values to approximate a normal
distribution with unit variance and zero mean. Some
necessary filters were designed for quality control: (a)
probesets with expression value lower than 100 or (b)
absolute Pearson value less than 0.2 or (c) present/
absent call less than 30% were excluded. Each gene was
represented by the probesets which had the largest abso-
lute Pearson correlation in each dataset in order to
remove multiple annotated probesets for the same gene.
In this way we obtained 2841, 3061, 2148 and 1201
unique genes within the four datasets respectively, giv-
ing 6120 unique genes in total.
The following formula was applied to calculate the
combined Z-score
ZT score i i
i
i
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ωi denotes the number of samples in each dataset (i.e.
40, 28, 35, 13); Ti indicates the normalized Pearson
association test statistic based on a t distribution.
At w o - t a i l e dP-value can be derived by the normal dis-
tribution for each gene from this combined Zscore. Bonf-
ferroni corrected FDR < 0.05 was applied, yielding the
top 34 genes which are most strongly co-expressed with
Nnat. For comparison we also applied Fisher’s Z-trans-
form to combine the transformed Pearson correlation
coefficients in the meta-analysis, we got similar results.
For the multi-species analysis, seven genes, Acp5, Tcta,
Znrf2, Serpina3c, S3-12, Sgce and Lrg1,w h i c ha r en o t
conserved in rat, were excluded.
Promoter analysis
To delineate the Nnat promoter, we identified the con-
served non-coding region of the Nnat locus in seven
mammalian genera (Pan, Bos, Canis, Mus, Sus, Rattus
and human). This corresponds to 1200 bp upstream and
800 bp downstream of the most utilized transcription
start points (TSP) of Nnat, identified through the pre-
sence of CAGED transcripts in mice and human. For
example, mouse Nnat has six transcripts, with two pro-
moters having respectively 36 and 28 CAGE tags, while
human NNAT has four transcripts with one promoter
having 29 CAGE tags. For these analyses we used the
Genome VISTA genome alignment tool http://www-gsd.
lbl.gov/vista/ in conjunction with Genomatix Gene2pro-
moter tool (Genomatix Software Inc., Ann Arbor, MI,
USA). The Genomatix MatInspector programme with
default parameter settings was used to detect common
Transcription Factor Binding Sites (TFBS) between the
seven promoter sequences of the seven genera. The
occurrence of the TFBSs within all vertebrate genes was
used as a control in MatInspector. Significant common
TFBSs among the seven species were defined by having
a p-value < 0.05 and presence in six or more species,
compared with the control sets in the Genomatix data-
base. We further explored the TF genes in each TFBSs
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they were expressed in human or mouse adipose,
hypothalamus and pancreas islet (using BioGPS database
http://biogps.gnf.org and our own BAIR data as refer-
ence sources). Promoter analysis was also applied to
these 27 fully conserved Nnat co-expression genes (plus
Nnat) all together, focusing on human, mouse and rat
only. Again, their expression status in adipose, hypotha-
lamus and pancreatic islets were included as well.
Gene set enrichment analysis
In order to inspect which biological pathways are signifi-
cantly correlated with Nnat expression in adipose tissue,
we employed Gene Set Enrichment Analysis, using the
GSEA package http://www.broadinstitute.org/gsea/ for
each of the above four datasets separately. We chose
Pearson correlation and permuted 1000 times to detect
statistical significance. Expression data were pre-filtered
by using the present/absent call and background correc-
tion, similarly to the pre-process in meta-analysis above.
In the GSEA database there were 200 KEGG pathway
sets and 639 canonical pathway sets. We first focused on
those approximately 100 KEGG gene sets which have
more than 15 genes and fewer than 500 genes; the results
returned were significant in the above four datasets as
well as an additional dataset which included 45 sleep
mice model with hypothalamus tissue (GEO: GSE6514).
We then worked on those canonical pathway sets which
passed the same filter only on BAIR fat-fed mice and
human fat dataset about 20 lean and 19 obese person[22].
Protein-protein interaction network analysis
By using BioNetBuilder, a cytoscape plugin package
http://err.bio.nyu.edu/cytoscape/bionetbuilder/ with sup-
ported databases DIP, BIND, Prolinks, KEGG, HPRD,
The BioGrid and GO, we thus generated a mouse pro-
tein-protein interaction network which had 11777
unique nodes (genes) and 107813 unique edges (links).
For the 27 fully conserved Nnat co-expression genes, we
searched each of their direct correlation genes (first
neighbours) in the PPI network, again filtered by expres-
sion value > 200 in adipose tissue by BioGPS.
Results
Nnat promoter analysis
We sought to investigate mechanisms of transcriptional
regulation of Nnat and of co-varying genes in adipose
tissue. The neuronatin gene is located on human chro-
mosome 20 and mouse chromosome 2. To define the
Nnat promoter we described the conserved non-coding
region in seven mammalian species, including mouse
and human, corresponding to 1200 bp upstream and
8 0 0b pd o w n s t r e a mo ft h em o st utilized transcription
start points (TSP) of Nnat identified through the
presence of CAGED transcripts in mice and humans.
We used Genomatix software to determine the presence
of binding sites for TF families in the conserved Nnat
promoter, across seven mammalian species. We then fil-
tered these potential regulators based on their expres-
sion in mouse WAT, and compared their expression
also in hypothalamus and pancreatic b-cells in which
Nnat is known to be expressed. Table 1 shows the gene
expression behaviour for members of TFBS families
scoring as significant for presence in the Nnat promoter
(p-value < 0.05), and present in at least six of the Nnat
promoter sequences; expression values were filtered on
the basis of BioGPS expression bigger than 200, which
therefore focuses attention on the most abundantly
expressed TFs.
The TFBS for the V$NEUR family (including NeuroD1
and NeuroD2)w a sf o u n dt ob eh i g h l ys i g n i f i c a n ti ns i x
out of seven promoter sequences, but it was not found
in the rat promoter sequences in our defined region.
However, V$NEUR does exist farther upstream from the
rat Nnat transcription start site (within 2.5kb). NeuroD1,
the only confirmed transcriptional regulator of Nnat
expression[14] is not one of the most highly expressed
TFs in adipose, though its expression value is similar
across all three tissues shown in Table 1, it is highly
expressed in cerebellum.
T h eb i n d i n gs i t e sf o rt h ek e ya d i p o s et i s s u er e g u l a t o r
Pparg are the most significant in the seven Nnat promo-
ter sequences. Of the TFs with conserved binding sites it
is also by far the most highly expressed in WAT, and has
a crucial role in adipocyte metabolism. Other important
TFs with conserved binding sites in the Nnat promoter
and which are highly expressed in WAT include several
genes which have crucial roles in the control of: adipo-
genesis (Klf15, Irf1, Creb1, Egr2, Gata3); lipogenesis
(Mlxipl, Srebp1c); inflammation (Jun, Stat3); insulin sig-
nalling and diabetes susceptibility (Foxo1, Tcf7l2). Inter-
estingly, the Rreb1 has a binding site in all seven Nnat
promoters, and is expressed at high levels in adipose and
hypothalamus. Rreb1 can enhance the transcription-
activating function of NeuroD1, a property that requires
both the physical interaction of Rreb1 with NeuroD1, and
binding of Rreb1 to DNA[23]. Notable by their absence
are binding sites for the C/EBP family of TFs, clearly sug-
gesting that this family (several members of which are
required for adipocyte differentiation) are not concerned
with Nnat regulation, and may be down-stream of Nnat.
Identification of biological pathways associated with Nnat
expression
In order to determine which biological pathways are
significantly correlated with Nnat expression in WAT
and hypothalamus, we employed Gene Set Enrichment
Analysis. Initially we focused on KEGG pathways to
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ciated with Nnat expression in WAT and hypothalamus.
In WAT, there are five KEGG pathways significantly
correlated with Nnat expression (FDR < 0.05) in at least
two of the four mouse WAT datasets (Table 2), these
five pathways are all significant in BAIR fat-fed data,
and include oxidative phosphorylation, ribosome,
proteasome, cholera infection and neuroactive ligand
receptor interaction, these last two indicating perturba-
tion of ion transport and neuronal function. Further-
more, oxidative phosphorylation, ribosome and cholera
infection are significant in the mouse hypothalamus
dataset as well. Additional file 1, Figure S1 illustrates
the enrichment plots and positively and negatively cor-
related genes in these three common pathways. Addi-
tional file 1, Table S1 lists the core enriched genes that
correlate with Nnat in these three common pathways in
both WAT and hypothalamus. GSEA on the canonical
pathways (Additional file 1, Table S2) reveals that Nnat
expression in mice on a high-fat diet and obese models
displayed highly positive correlations with inflammatory
pathways (complement and coagulation, cytokine and
integrin signalling), and strongly negative correlations
with metabolic pathways (most prominently oxidative
phosphorylation, pyruvate metabolism, glycolysis and
gluconeogenesis) and protein turnover (including pro-
teasome, ribosome and mRNA processing). In human
adipose tissue NNAT mRNA expression is decreased
(Additional file 1, Table S3). In consequence NNAT
expression displayed strong positive correlation with
genes involved in protein turnover and fatty acid meta-
bolism/degradation, and negatively correlated with genes
involved in adhesion, complement and coagulation and
cytokine. Additional file 1, Table S4 lists the common
pathways correlated with Nnat expression between
BAIR fat-fed mice and human obese WAT, and these
are concerned with cytokine signalling and cell-cell
interaction. Additional file 2, Table S5 contains the
complete list of genes associated with Nnat in each
KEGG pathway in mouse models.
Identification of genes that co-vary with Nnat
The genes whose expression co-varies with Nnat are
likely to share regulatory mechanisms and, perhaps,
Table 1 Expression of conserved TFBS in Nnat promoter
TFs TFBSs p-value WAT hypo panc TFs TFBSs p-value WAT hypo panc
Pparg V$PPAR 0 11959 253 357 Hsf2 V$HEAT 0.0202 271 543 279
Zfp161 V$ZF5F 2E-05 1309 1537 523 Tef V$PARF 0.0209 4845 5297 846
Rreb1 V$RREB 0.0005 3530 1344 117 Myb V$MYBL 0.0217 730 51 81
Tead4 V$TEAF 0.0005 271 239 367 Meox2 V$HBOX 0.0221 555 37 47
Hes2 V$HESF 0.0016 468 304 498 Stat3 V$STAT 0.0236 3754 1438 617
Gtf2i V$DICE 0.002 5309 7006 398 Myt1l V$MYT1 0.0247 327 1039 395
Zfp384 V$CIZF 0.0023 1966 989 1073 Neurod1 V$NEUR 0.0262 119 323 224
Myog V$MYOD 0.0024 523 524 638 Neurod2 V$NEUR 0.0262 209 216 237
Glis2 V$GLIF 0.0026 308 365 390 Hand1 V$HAND 0.0283 557 519 662
Mef2d V$MEF2 0.0027 2451 4184 668 Bcl6 V$BCL6 0.0301 4569 1672 82
Tcf7l2 V$LEFF 0.0033 4252 1922 329 Gata3 V$GATA 0.0323 432 54 72
Ctcf V$CTCF 0.004 2655 1586 890 Pbx2 V$PBXC 0.0345 524 456 253
Srf V$SRFF 0.0041 340 275 212 Hoxd9 V$ABDB 0.0364 230 139 190
Zfp219 V$ZBPF 0.0042 1282 1712 270 Hoxc8 V$HOXF 0.0371 1804 203 364
Hif1a V$HIFF 0.0042 542 564 194 Evi1 V$EVI1 0.0412 274 240 335
Mlxipl V$EBOX 0.006 304 27 32 Creb1 V$CREB 0.0415 2387 1157 532
Nfat5 V$NFAT 0.0069 1154 842 203 Jun V$CREB 0.0415 2503 1955 1735
Egr2 V$EGRF 0.0078 408 141 289 Klf15 V$KLFS 0.0419 7360 2193 2438
Tfdp1 V$E2FF 0.0125 1993 1575 77 Klf4 V$KLFS 0.0419 4878 593 348
Pou6f1 V$BRN5 0.0146 632 973 446 Klf6 V$KLFS 0.0419 3219 583 895
Sp1 V$SP1F 0.0147 322 200 306 Foxo1 V$FKHD 0.0424 400 129 106
Dmrt2 V$DMRT 0.0157 275 28 57 Sox4 V$SORY 0.043 4829 1217 74
Nfyc V$CAAT 0.0161 2207 914 247 Pou2f1 V$OCT1 0.0443 225 229 238
Irf1 V$IRFF 0.0166 5486 259 196 Elf1 V$ETSF 0.0464 2419 78 134
Ahr V$AHRR 0.0171 483 135 62 Nr2f2 V$NR2F 0.0472 6090 8397 259
Nfia V$NF1F 0.0171 3505 2335 505 Rxrb V$RXRF 0.0479 1715 1309 1944
Lhx4 V$LHXF 0.0177 269 242 225 Msx1 V$HOMF 0.0479 392 360 435
Conserved TFBS found in Nnat promoter region across seven mammalian species and their gene expression in three tissues of mice.
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whose expression is highly correlated with Nnat in a
meta-analysis of WAT gene expression data. Table 3
shows the correlation of gene expression behaviour with
that of Nnat, in four microarray datasets; entries with a
null value indicate that this gene is missing in the speci-
fic dataset; their fold change information in BAIR fat-fed
mice and human with obesity are shown in Table 4.
Additional file 1, Figure S2 gives the hierarchical clus-
tering for these 28 genes in BAIR fat-fed dataset, here
genes with expression most closely associated with Nnat
include Aqp1, Sncg, Sulf2 and Cxcl9. Additional file 1,
Figure S3 illustrates the expressions of the top four
most correlated genes (Gstt1, Ccdc80, Hfe Sod3)w i t h
Nnat in BAIR and GSE6571 datasets. Among these
genes is only one transcription factor, Ebf1 which has
previously been suggested to have a regulatory role in
adipogenesis[24]. Another of the Nnat-correlated genes,
Lgals12, is a member of the galectin family of beta-
galactoside-binding proteins, and is a major regulator of
adipose tissue development[25].
In order to investigate whether these 27 genes share
conserved TFBS with Nnat as identified in Table 1, we
used Genomatix tools to analyze the promoters of all 28
genes in human, mouse and rat separately. We found
that nine TFBS families in Table 1, V$CREB, V$EVI1, V
$GATA, V$KLFS, V$NR2F, V$RXRF, V$SORY, V$STAT,
V$HAND, which are conserved in the promoter region of
Nnat from seven species, are significant TFBS of all these
28 genes in human, mouse and rat, indicating these
TFBSs are likely to be important in WAT. We also found
that V$RREB and V$TEAF a r eh i g h l ys i g n i f i c a n tT F B S s
(p-value < 3.31e-10, p-value < 6.22e-8, p-value < 5.58e-7)
in most of the 28 genes, while V$PPAR is highly significant
(p-value < 5.7e-4, p-value < 4.14e-6, p-value < 5.7e-4) half
in of the 28 genes (Table 5).
We used the Genomatix Promoter Module Library
a n dw e r ea b l et oi d e n t i f yh i g h l yc o n s e r v e dm o d e l so f
five transcription factor elements highly conserved
across the Nnat promoter. Among these promoter
sequences, we got 20 significant models which consist
of elements from five transcription factor family. Figure
1 shows TFBPs for V$EVI1 - V$EGRF - V$E2FF - V
$NRF1 - V$LEFF, on the Nnat promoter close together
in a similar region for six species separately just
upstream of the major TSP. V$EVI1 - V$EGRF - V
$ E 2 F Fa n d- V $ L E F Fa r ei nT a b l e1a n dT Fm e m b e r so f
these families are expressed in WAT, hypothalamus and
pancreas. V$EVI1 - V$EGRF and - V$LEFF in Table 5
indicate conservation in the promoters of genes that
co-vary with Nnat. There are important transcription
factors in these families, for example Egr2 and Tcf7l2,
which are implicated in stress responses and T2D; E2f
which is concerned with adipogenesis and Evi1,w h i c h
activates Stat3, a transcription factor concerned with
leptin signalling in the hypothalamus.
Functional networks formed by genes that co-vary
with Nnat
In the mouse PPI network, we sought Nnat,a n dt h e2 7
genes that co-vary with it, and their respective first
neighbours. 21 of the 27 Nnat co-expression genes can
be mapped to this PPI network, which contains 375 first
neighbours, leading to a sub-network with a total of 396
Table 2 Pathways associated with Nnat
KEGG Pathway Size p-value FDR Correlation Tissue
OXIDATIVE_PHOSPHORYLATION 92 < 0.001 < 0.001 Negative WAT
RIBOSOME 52 < 0.001 < 0.001 Negative WAT
PROTEASOME 22 < 0.001 < 0.001 Negative WAT
CHOLERA_INFECTION 33 < 0.001 < 0.01 Negative WAT
NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION 36 < 0.001 < 0.01 Positive WAT
OXIDATIVE_PHOSPHORYLATION 93 < 0.001 0.011 Negative Hypo
RIBOSOME 52 < 0.001 0.006 Negative Hypo
CHOLERA_INFECTION 32 < 0.001 0.031 Positive Hypo
ALANINE_AND_ASPARTATE_METABOLISM 25 < 0.002 0.029 Positive Hypo
ARGININE_AND_PROLINE_METABOLISM 18 < 0.001 0.026 Positive Hypo
TRYPTOPHAN_METABOLISM 31 < 0.001 0.025 Positive Hypo
SELENOAMINO_ACID_METABOLISM 21 0.004 0.029 Positive Hypo
THYROID_CANCER 21 0.003 0.025 Positive Hypo
BUTANOATE_METABOLISM 29 0.004 0.036 Positive Hypo
GALACTOSE_METABOLISM 16 0.006 0.04 Positive Hypo
GLYCOLYSIS_AND_GLUCONEOGENESIS 30 0.004 0.05 Positive Hypo
PATHOGENIC_ESCHERICHIA_COLI_INFECTION_EHEC 24 0.008 0.049 Positive Hypo
Significant pathways associated with Nnat analyzed by GSEA.
Li et al. BMC Systems Biology 2010, 4:175
http://www.biomedcentral.com/1752-0509/4/175
Page 6 of 11nodes and 3804 edges. Among these genes, 191 (48%)
are expressed in hypothalamus (including 11 of the 21
Nnat co-varying genes) and 275 (69%) are expressed in
WAT (including all 21 of the Nnat co-expression
genes), 190 (48%) are expressed in pancreas (including 8
of the 21 Nnat co-varying genes, all expressed in
hypothalamus as well). The functional groups formed by
the PPI involving the 21 Nnat co-varying genes (exam-
ples given in parentheses with sentinel gene embol-
dened) correspond to the following major biological
functions: (1) cellular stress, inflammation, adipocyte
metabolism, metabolic syndrome and type 2 diabetes
(Sncg, Erk1/2, Jnk, Hnf4a and Fabp4); (2) detoxification
of aldehydes, retinol and products of oxygen free radical
metabolism (Aoc3, Aldh1a3/9a1, Rdh11/12/13); (3) local
natriuretic peptide system and growth (Npr3, Nppa); (4)
glutathione and xenobiotic metabolism (Gstt1/3,
Cyp1a1/1b1); (5) iron metabolism (Hfe and Tfrc); (6)
Wnt signaling (Fzd6, Sfrp1 and Wtn11); (7) adipogenesis
(Ebf1, Ebf4, Crebbp, Ep300 ); (8) protein turnover
(Rad50, Eif4a1, Psmc4 and Ube2b); (9) integrins,
neurodegeneration, and metabolic, inflammatory and
growth-control signalling (Cav1, Ngfr, Tnfrsf1b, Hras1,
P t e n ,A p p ,H n f 4 aand Esr). Figure 2 shows a sub-
network with genes expressed in WAT, hypothalamus
and pancreatic b-cells, which has 151 nodes and 447
links. Eight genes that co-vary with Nnat in the three
tissues are shown in yellow, and comprise: Anxa6, Cav1,
Cd151, Gstt1, Map1lc3a, Npdc1, Npr3, and Sncg. Nnat
does not appear since it is not included in the mouse
PPI database.
Discussion
This study explored the behaviour of the diet-responsive
gene Nnat in multiple gene expression datasets from
mouse adipose tissue, and subsequently analysed in
silico the promoter of Nnat in seven mammalian spe-
cies. Rosen and MacDougald[24] have pointed out that
at least 100 TFs are expressed in adipocyte, and our
analyses here have sought to focus attention on those
which could play a part in the regulation of expression
of Nnat and its co-varying genes. Based on our study we
Table 3 Co-expression genes with Nnat in WAT
Genes GSE8831 GSE4671 BAIR DGAP meta.z p-value FDR
GSTT1 0.33 0.92 0.87 0.71 6.16 7.50E-10 4.59E-06
CCDC80 0.36 0.93 0.86 5.82 5.85E-09 3.58E-05
HFE 0.71 0.93 0.71 5.81 6.37E-09 3.90E-05
SOD3 0.64 0.84 0.79 0.51 5.55 2.93E-08 0.0002
NPDC1 0.67 0.92 0.62 0.7 5.44 5.47E-08 0.0003
AQP1 0.68 0.71 0.8 0.47 5.37 7.73E-08 0.0005
EBF1 0.62 0.84 0.81 5.3 1.15E-07 0.0007
SNCG 0.81 0.58 0.72 5.28 1.30E-07 0.0008
LGALS12 0.95 0.83 5.15 2.57E-07 0.0016
SLC6A13 0.73 0.8 0.7 0.4 5.1 3.43E-07 0.0021
HEBP1 0.73 0.84 0.69 5.09 3.53E-07 0.0022
NPR3 0.66 0.71 0.77 0.54 5.07 4.04E-07 0.0025
RAD50 0.63 0.35 0.85 5.06 4.16E-07 0.0025
H6PD 0.54 0.85 0.77 0.53 5.04 4.57E-07 0.0028
HTRA3 0.48 0.95 0.67 5.01 5.76E-07 0.0035
ART3 0.63 0.81 0.77 4.95 7.28E-07 0.0045
CAV1 0.67 0.73 0.78 4.95 7.46E-07 0.0046
AOC3 0.27 0.95 0.76 0.25 4.94 7.73E-07 0.0047
ANXA6 0.65 0.73 0.73 0.57 4.84 1.29E-06 0.0079
CXCL9 0.33 0.53 0.88 4.71 2.51E-06 0.0154
JUP 0.55 0.79 0.62 0.89 4.7 2.60E-06 0.0159
BLCAP 0.5 0.9 0.61 0.76 4.65 3.30E-06 0.0202
FZD4 0.49 0.73 0.79 0.5 4.63 3.62E-06 0.0221
SULF2 0.88 0.86 4.63 3.68E-06 0.0226
CD151 0.83 0.87 0.46 4.62 3.79E-06 0.0232
MAP1LC3A 0.68 0.78 0.59 0.67 4.56 5.05E-06 0.0309
EPN2 0.54 0.91 0.53 0.71 4.48 7.42E-06 0.0454
High significant co-expression genes with Nnat in WAT based on gene expression meta-analysis. This table shows the Pearson correlation coefficient value of
each gene in each of the four microarray datasets, blank value means that the relevant gene is not expressed (not passed the QC or even not included into the
microarray chip). Top combined meta-zscore, meta-pvalue and FDR test are shown by FDR < 0.05.
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Page 7 of 11find 50 TFBSs conserved across seven species on the
Nnat promoter, and expression of the TFs corresponding
to these in adipose tissue, many of which have known
roles in adipocyte processes including, adipogenesis
(K l f 1 5 ,I r f 1 ,C r e b 1 ,E g r 2 ,G a t a 3 ); lipogenesis (Mlxipl,
Srebp1c); inflammation (Jun, Stat3); insulin signalling and
diabetes susceptibility (Foxo1, Tcf7l2). These TFs are also
well expressed in the hypothalamus and pancreas.
NeuroD1 is the only confirmed transcription factor for
Nnat, whose expression regulates in the developing pan-
creas[14]. Binding sites for the TF family V$NEUR
(which includes NeuroD1 and NeuroD2) are predicted in
six of the seven mammalian Nnat proximal promoter
regions examined here (all except rat), and are also pre-
sent further upstream in the rat Nnat promoter region.
Members of this family are expressed at reasonable
levels in all three mouse tissues analysed here, so it
remains possible that the V$NEUR family participates in
Nnat regulation in several tissues. NeuroD1 is consid-
ered to be a weak activator of transcription, but is
known to cooperate with other transcription factors,
including Rreb1 and Sp1[23,26], in the stimulation of
gene expression. Binding sites for both of these families
are conserved in the Nnat promoter across mammalian
species, as well as in the promoters for the Nnat
co-varying genes analysed above. Indeed this property
requires both the physical interaction of Rreb1 with
NeuroD1, and binding of Rreb1 to DNA. Direct evidence
for such a mechanism of regulation requires experimen-
tal validation. The expression of Nnat remains strong in
the developing pituitary of NeuroD1 knockout mice
[14], so it is clear that different TFs (or combinations
thereof) are likely to be of varying importance in regu-
lating Nnat expression in different tissues.
Table 5 Common TFBS among Nnat and its co-vary genes
TFBS hs_pval mm_pval rat_pval #hs #mm #rat
V$PPAR 5.70E-04 4.14E-06 5.70E-04 12 15 12
V$ZF5F 1.62E-06 2.34E-04 0.0033 18 15 13
V$RREB 3.31E-10 6.22E-08 5.58E-07 26 24 23
V$TEAF 6.22E-08 6.22E-08 5.34E-09 24 24 25
V$STAT 9.89E-09 1.29E-07 8.77E-06 26 25 23
V$HESF 2.35E-09 4.30E-08 2.83E-05 27 26 23
V$MYOD 1.29E-08 1.69E-05 9.92E-05 27 24 23
V$GLIF 5.36E-09 3.90E-06 3.00E-07 28 26 27
V$MEF2 0.0025 2.52E-05 0.0025 21 24 21
V$LEFF 0.0042 5.25E-05 2.80E-04 21 24 23
V$CTCF 9.37E-05 1.43E-05 1.59E-06 24 25 26
V$SRFF 1.50E-05 0.002 1.67E-06 25 22 26
V$ZBPF 1.23E-06 2.30E-08 1.23E-06 27 28 27
V$HIFF 2.45E-07 8.69E-12 2.45E-07 22 26 22
V$EBOX 8.80E-06 6.89E-05 1.34E-08 26 25 28
V$NFAT 5.79E-05 5.79E-05 0.0025 27 27 25
V$EGRF 1.84E-04 2.35E-06 1.84E-04 25 27 25
V$SP1F 8.94E-06 8.94E-06 8.94E-06 27 27 27
V$CAAT 2.19E-06 2.19E-06 1.00E-04 28 28 27
V$CART 0.0029 0.0029 0.0029 25 25 25
V$IRFF 6.53E-04 0.0034 6.53E-04 26 25 26
V$NF1F 4.37E-06 5.72E-08 4.37E-06 23 25 23
V$AHRR 6.01E-07 6.07E-08 1.42E-04 24 25 21
V$HEAT 0.0015 2.07E-04 2.07E-04 26 27 27
V$MYBL 0.0021 3.12E-04 7.05E-06 26 27 28
V$STAT 1.38E-05 1.38E-05 1.38E-05 28 28 28
V$NEUR 1.64E-04 2.64E-05 3.09E-06 24 25 26
V$HAND 2.30E-04 2.30E-04 2.30E-04 28 28 28
V$BCL6 5.24E-06 0.0027 3.39E-05 24 20 23
V$GATA 6.49E-05 6.49E-05 6.49E-05 28 28 28
V$EVI1 3.23E-04 3.23E-04 3.23E-04 28 28 28
V$CREB 3.64E-04 3.64E-04 3.64E-04 28 28 28
V$KLFS 6.56E-04 6.56E-04 6.56E-04 28 28 28
The common TFBS among the 28 (Nnat and its co-vary) genes in three
species respectively. The last three columns give the number of promoter
sequences among the 28 which share the same TFBS in their promoter
sequences.
Table 4 The fold change of co-expression genes
Genes BAIR.2d BAIR.8d BAIR.3w BAIR.15w Human
NNAT 7.82 3.54 1.02 1.19 0.72
GSTT1 2.5 1.43 1.1 0.89 0.86
CCDC80 2.65 2.2 0.69 1.05 2.57
HFE 1.59 1.16 0.77 1.34 0.87
SOD3 1.99 1.64 0.87 1.45 0.89
NPDC1 1.28 1.14 0.92 0.96 1.88
AQP1 1.64 1.32 1.27 1.01 1.52
EBF1 2.07 1.54 0.89 1.28 0.68
SNCG 6.16 8.06 1.53 1.53 1.26
LGALS12 3.12 1.47 0.89 0.93 1.03
SLC6A13 2.09 1.74 0.54 1.89 0.77
HEBP1 1.35 1.18 0.77 1 1.08
NPR3 5.28 3.14 0.7 2.87 1.69
RAD50 2.02 1.67 0.85 1.24 0.71
H6PD 1.82 1.38 1.05 0.95 1.16
HTRA3 1.65 1.23 0.8 1.27 1.12
ART3 2.03 1.41 0.92 0.88 1.33
CAV1 1.48 1.18 0.88 1.14 0.93
AOC3 1.91 1.11 0.75 1.37 0.83
ANXA6 1.64 1.59 0.97 1.4 0.85
CXCL9 3.48 2.3 1.26 1.25 1.22
JUP 1.54 1.07 0.89 1 1.06
BLCAP 1.58 1.11 1.03 1.1 0.92
FZD4 2.24 1.42 0.88 1.9 1.11
SULF2 1.59 1.31 1 1.11 2.08
CD151 1.54 1.23 0.95 1.18 1.1
MAP1LC3A 1.32 0.95 1.03 1.32 0.93
EPN2 1.14 1.03 1.18 1.17 1.24
This table shows the fold change (FC) of those co-expression genes of Nnat in
adipose tissue in fat-fed mice during development of diet-induced obesity,
and in human obese adipose tissue.
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Page 8 of 11Pparg is both necessary and sufficient for adipocyte dif-
ferentiation of fibroblast/pre-adipocyte cell lines [24] and
the presence, in all the Nnat promoters analysed here, of
Pparg binding sites is consistent with it playing a role in
regulation of Nnat expression in WAT. Nnat expression
is strongly reduced in WAT of a mouse model in which a
dominant negative version of Pparg is expressed[17].
Activation of Pparg with Pparg agonists improves insulin
signalling and decreases inflammation. This is consistent
with the view that Nnat protects against toxins and is
concerned with resolution of tissue injury. Indeed our
unpublished results in 3T3L1 cells, where we have over
expressed Nnat indicate an anti-inflammatory function.
However there is currently no evidence on whether
Pparg plays a direct role in the regulation of Nnat.L i k e -
wise, in mice expressing an inactive mutant version of
Srebp1c, Nnat expression in WAT is severely reduced as
well[17]. In both of these mouse models complex
changes in WAT gene expression make it difficult to
draw conclusions as to the regulation of particular genes
by specific TFs. Pparg is known to operate in a cellular
network with other TFs of the EBF, C/EBP, KLF and IRF
families in regulating adipogenesis[24,27-29]. Our bioin-
formatical analysis suggests that Pparg could be a candi-
date for Nnat regulation, meanwhile the absence of V
$SREB binding sites in the Nnat promoter does not sup-
port a direct role for Srebp1c.
The pattern of gene expression observed in the mouse
WAT upon high fat feeding in experiments analysed here
suggests a critical in oxidative stress; indeed sentinel
indicators of this Gstt1, Ccdc80, Hfe and Sod3 all con-
cerned with cellular management of free radicals are the
genes most highly correlated with Nnat in the meta-ana-
lysis (Additional file 1, Figure S3). Genes concerned with
adipogenesis (Ebf1, Fzd4 and Lgals12)a n di n f l a m m a t i o n
(Sncg, Cxcl9 and Aoc3) are also highly correlated in
mouse WAT upon high fat feeding (Additional file 1,
Figure S2). This is consistent with data indicating that
Nnat expression favours adipogenesis and inflammation.
Of the aforementioned adipogenic TFs, only Ebf1 expres-
sion correlates well with Nnat,b u tt h ec o n s e r v e dNnat
promoter does not possess Ebf1 binding sites (TF family
V$NOLF). Thus it is unlikely that Ebf1 regulates Nnat
expression; instead they may both be targets of the same
TFs. By treating the Nnat co-varying genes as a set, and
carrying out promoter analysis on this set, we discovered
that many wide-acting TFs have binding sites in all of
these genes. This does not itself indicate which, if any, of
these TFs may regulate the Nnat co-varying genes, but
does draw attention to the families V$HIFF (example:
HIF1a) V$RREB (example: Rreb1) and V$TEAF (example:
Tead4)a sb e i n gt h em o s th i g h l yo ver-represented TFBS
in this group of genes.
Our gene set enrichment analysis showed that expres-
sion of Nnat is strongly negatively correlated with energy
metabolism (most notably oxidative phosphorylation) and
positively correlated with inflammation. Repression of oxi-
dative phosphorylation gene expression is one of the
major changes seen in human diabetes[21], and a meta-
bolic/inflammatory network is thought to underlie
Figure 1 Transcription factor module in six Nnat promoter sequences. There are 20 significant five-element modules found in the six
promoter sequences of Nnat for six species (Human, Mus, Can, Sus, Bos, Rat), sequence in 1200 bp upstream and 800 bp downstream, here
shows TFBSs for V$EVI1 - V$EGRF - V$E2FF - V$NRF1 - V$LEFF, on the Nnat promoter closely and together in the similar region of the six species
separately just upstream of the major TSP.
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Page 9 of 11metabolic syndrome in susceptible mice[30]. Although in
the human data NNAT expression is not correlated with
oxidative phosphorylation in the GSEA in a more general
analysis of gene expression in this human data the oxida-
tive phosphorylation gene set is enriched. We would
expect that major changes in gene set regulation require
the participation of wide-acting TFs and/or extensive net-
works of TFs and their cofactors.
We found 27 genes that show strong co-variation with
Nnat. 21 of these can be mapped to the PPI network,
and eight of these (Anxa6, Cav1, Cd151, Gstt1,
Map1lc3a, Npdc1, Npr3, and Sncg) are expressed in adi-
pose tissue, pancreas and hypothalamus. App and
Tcf7l2, genes implicated in metabolic inflammation,
Alzheimer’s disease and diabetes are shown linked to
their respective first neighbours (Figure 2). Sncg along
with Nnat is a leptin responsive gene[11].
Conclusions
In conclusion we identify numerous TFBSs, conserved
among mammals, on the Nnat promoter, and expression
of TFs corresponding to these in adipose tissue,
hypothalamus and pancreas. Many of these have known
roles in adipocyte, as well as pancreatic and hypothala-
mic processes. We observe clustering of TFBSs for Egr1
and Tcf7l2, which are implicated in stress responses and
T2D; E2f which is concerned with adipogenesis and
Evi1, a developmental gene highly expressed in
Figure 2 Mouse Nnat co-expression gene tissue-specific PPI network. All Nnat co-expression genes in Table 3 and their first neighbours in
mouse PPI network showing expressed in WAT, hypothalamus and pancreas, generated a tissue-specific network with 151 nodes and 447 links.
The eight genes in yellow are Nnat co-varying genes in Table 3. Two obesity relative genes App and Tcf7l2 and their direct associated genes
linked by red edges.
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Page 10 of 11pancreatic islets. GSEA anal y s i ss u g g e s t st h er o l e sf o r
Nnat in oxidative stress, resolution of inflammation,
energy metabolism, mainly oxidative phosphorylation,
and protein turnover. Genes that co-vary with Nnat,
such as S n c g ,G s t t 1 ,H f eand Ebf1,s h a r es o m eo ft h e s e
TFBSs and form functional networks. The recent
demonstration that SNPs in Nnat are found in obese
humans suggest that altered Nnat function in adipose
tissue or the hypothalamus may be involved in the
pathogenesis of obesity via such mechanisms.
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